Publika - Scientific publications from Oslo University Hospital

RSS feed RSS

Publications (original articles or review articles) published in 2006 from OUS - Department of Cardiology B (Div Med)

78 publications found

Abedin M, Omland T, Ueland T, Khera A, Aukrust P, Murphy SA, Jain T, Gruntmanis U, McGuire DK, de Lemos JA (2006)
Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study)
Am J Cardiol, 99 (4), 513-8
DOI 10.1016/j.amjcard.2006.08.064, PubMed 17293196

Ahmed MS, Øie E, Vinge LE, von Lueder TG, Attramadal T, Attramadal H (2006)
Induction of pulmonary connective tissue growth factor in heart failure is associated with pulmonary parenchymal and vascular remodeling
Cardiovasc Res, 74 (2), 323-33
DOI 10.1016/j.cardiores.2006.12.010, PubMed 17254558

Aksnes TA, Kjeldsen SE, Mancia G (2006)
The effect of antihypertensive agents on new-onset diabetes mellitus: time to amend the guidelines?
Am J Cardiovasc Drugs, 6 (3), 139-47
DOI 10.2165/00129784-200606030-00001, PubMed 16780387

Aksnes TA, Reims HM, Guptha S, Moan A, Os I, Kjeldsen SE (2006)
Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors
J Hum Hypertens, 20 (11), 860-6
DOI 10.1038/sj.jhh.1002087, PubMed 16988754

Amundsen AL, Khoury J, Sandset PM, Seljeflot I, Ose L, Tonstad S, Henriksen T, Retterstøl K, Iversen PO (2006)
Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia
Thromb Res, 120 (1), 21-7
DOI 10.1016/j.thromres.2006.07.001, PubMed 16914186

Andersen GØ, Eritsland J, Aasheim A, Neuburger J, Knudsen EC, Mangschau A (2006)
[Impaired glucose tolerance in patients with acute myocardial infarction]
Tidsskr Nor Laegeforen, 126 (17), 2264-7
PubMed 16967066

Atar D, Huber K, Rupprecht HJ, Kopecky SL, Schwitter J, Theek C, Brandl K, Henning R, Geudelin B (2006)
Rationale and design of the 'F.I.R.E.' study. A multicenter, double-blind, randomized, placebo-controlled study to measure the effect of FX06 (a fibrin-derived peptide Bbeta(15-42)) on ischemia-reperfusion injury in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
Cardiology, 108 (2), 117-23
DOI 10.1159/000095982, PubMed 17019083

Atar D, Malinin A, Takserman A, Pokov A, van Zyl L, Tanguay JF, Lesperance F, Serebruany V (2006)
Escitalopram, but not its major metabolites, exhibits antiplatelet activity in humans
J Clin Psychopharmacol, 26 (2), 172-7
DOI 10.1097/, PubMed 16633147

Bethune C, Seierstad SL, Seljeflot I, Johansen O, Arnesen H, Meltzer HM, Rosenlund G, Frøyland L, Lundebye AK (2006)
Dietary intake of differently fed salmon: a preliminary study on contaminants
Eur J Clin Invest, 36 (3), 193-201
DOI 10.1111/j.1365-2362.2006.01612.x, PubMed 16506965

Bilenko V, Bilenko N, Harman-Boehm I, Atar D, Rosen S, Weitzman S (2006)
[Trends and characteristics of diabetes-related lower limb amputations in the Negev, 1996-1999]
Harefuah, 145 (10), 709-12, 784
PubMed 17111702

Birkeland JA, Sjaastad I, Brattelid T, Qvigstad E, Moberg ER, Krobert KA, Bjørnerheim R, Skomedal T, Sejersted OM, Osnes JB, Levy FO (2006)
Effects of treatment with a 5-HT4 receptor antagonist in heart failure
Br J Pharmacol, 150 (2), 143-52
DOI 10.1038/sj.bjp.0706966, PubMed 17160012

Christensen MK, Olsen MH, Wachtell K, Tuxen C, Fossum E, Bang LE, Wiinberg N, Devereux RB, Kjeldsen SE, Hildebrandt P, Rokkedal J, Ibsen H (2006)
Does long-term losartan- vs atenolol-based antihypertensive treatment influence collagen markers differently in hypertensive patients? A LIFE substudy
Blood Press, 15 (4), 198-206
DOI 10.1080/08037050600962968, PubMed 17078155

Dammen T, Bringager CB, Arnesen H, Ekeberg O, Friis S (2006)
A 1-year follow-up study of chest-pain patients with and without panic disorder
Gen Hosp Psychiatry, 28 (6), 516-24
DOI 10.1016/j.genhosppsych.2006.08.005, PubMed 17088168

Daniels LB, Clopton P, Bhalla V, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA, Maisel AS (2006)
How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study
Am Heart J, 151 (5), 999-1005
DOI 10.1016/j.ahj.2005.10.011, PubMed 16644321

Demyanets S, Pfaffenberger S, Kaun C, Rega G, Speidl WS, Kastl SP, Weiss TW, Hohensinner PJ, Dietrich W, Tschugguel W, Bochkov VN, Awad EM, Maurer G, Huber K, Wojta J (2006)
The estrogen metabolite 17beta-dihydroequilenin counteracts interleukin-1alpha induced expression of inflammatory mediators in human endothelial cells in vitro via NF-kappaB pathway
Thromb Haemost, 95 (1), 107-16
PubMed 16543969

Dudman SG, Trøseid M, Jonassen TØ, Steinbakk M (2006)
[Whooping cough--an increasing problem in Norway]
Tidsskr Nor Laegeforen, 126 (3), 305-8
PubMed 16440035

Eid HM, Arnesen H, Hjerkinn EM, Lyberg T, Ellingsen I, Seljeflot I (2006)
Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine
Nutr Metab (Lond), 3, 4
DOI 10.1186/1743-7075-3-4, PubMed 16396682

Eid HM, Lyberg T, Arnesen H, Seljeflot I (2006)
Insulin and adiponectin inhibit the TNFalpha-induced ADMA accumulation in human endothelial cells: the role of DDAH
Atherosclerosis, 194 (2), e1-8
DOI 10.1016/j.atherosclerosis.2006.11.008, PubMed 17141242

Ellingsen I, Hjerkinn EM, Arnesen H, Seljeflot I, Hjermann I, Tonstad S (2006)
Follow-up of diet and cardiovascular risk factors 20 years after cessation of intervention in the Oslo Diet and Antismoking Study
Eur J Clin Nutr, 60 (3), 378-85
DOI 10.1038/sj.ejcn.1602327, PubMed 16306931

Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B (2006)
ESH-ESC guidelines for the management of hypertension
Herz, 31 (4), 331-8
DOI 10.1007/s00059-006-2829-3, PubMed 16810473

Estensen ME, Hognestad A, Syversen U, Squire I, Ng L, Kjekshus J, Dickstein K, Omland T (2006)
Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction
Am Heart J, 152 (5), 927.e1-6
DOI 10.1016/j.ahj.2006.05.008, PubMed 17070161

Flaa A, Kjeldsen SE (2006)
Are all the hypertensives made equal?
Herz, 31 (4), 323-30
DOI 10.1007/s00059-006-2782-1, PubMed 16810472

Flaa A, Mundal HH, Eide I, Kjeldsen S, Rostrup M (2006)
Sympathetic activity and cardiovascular risk factors in young men in the low, normal, and high blood pressure ranges
Hypertension, 47 (3), 396-402
DOI 10.1161/01.HYP.0000203952.27988.79, PubMed 16446389

Fossum E, Olsen MH, Høieggen A, Wachtell K, Reims HM, Kjeldsen SE, Ibsen H, Wan Y, Julius S (2006)
Long-term effects of a losartan- compared with an atenolol-based treatment regimen on carotid artery plaque development in hypertensive patients with left ventricular hypertrophy: ICARUS, a LIFE substudy
J Clin Hypertens (Greenwich), 8 (3), 169-73
DOI 10.1111/j.1524-6175.2006.04838.x, PubMed 16522993

Gortzak Y, Mercado E, Atar D, Weisel Y (2006)
Pediatric olecranon fractures: open reduction and internal fixation with removable Kirschner wires and absorbable sutures
J Pediatr Orthop, 26 (1), 39-42
DOI 10.1097/01.bpo.0000187988.86892.a2, PubMed 16439899

Hegbom F, Sire S, Heldal M, Orning OM, Stavem K, Gjesdal K (2006)
Short-term exercise training in patients with chronic atrial fibrillation: effects on exercise capacity, AV conduction, and quality of life
J Cardiopulm Rehabil, 26 (1), 24-9
DOI 10.1097/00008483-200601000-00005, PubMed 16617223

Hegbom F, Stavem K, Sire S, Heldal M, Orning OM, Gjesdal K (2006)
Effects of short-term exercise training on symptoms and quality of life in patients with chronic atrial fibrillation
Int J Cardiol, 116 (1), 86-92
DOI 10.1016/j.ijcard.2006.03.034, PubMed 16815571

Henareh L, Jogestrand T, Agewall S (2006)
Microalbuminuria in patients with previous myocardial infarction
Kidney Int, 69 (1), 178-83
DOI 10.1038/, PubMed 16374441

Hjerkinn EM, Abdelnoor M, Breivik L, Bergengen L, Ellingsen I, Seljeflot I, Aase O, Ole Klemsdal T, Hjermann I, Arnesen H (2006)
Effect of diet or very long chain omega-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia
Eur J Cardiovasc Prev Rehabil, 13 (3), 325-33
DOI 10.1097/01.hjr.0000209817.28444.fb, PubMed 16926660

Hodt A, Steine K, Atar D (2006)
[Medical and ventilatory treatment of acute heart failure]
Tidsskr Nor Laegeforen, 126 (6), 749-52
PubMed 16541166

Hodt A, Steine K, Atar D (2006)
Medical and ventilatory treatment of acute heart failure: new insights
Cardiology, 106 (1), 1-9
DOI 10.1159/000092410, PubMed 16582544

Hoffmann P, Halvorsen S, Stensaeth KH, Brekke M, Müller C, Anker GO, Abdelnoor M, Kløw NE (2006)
Myocardial perfusion in ST-elevation myocardial infarction treated successfully with primary angioplasty
Scand Cardiovasc J, 40 (2), 96-104
DOI 10.1080/14017430600628144, PubMed 16608779

Jensen JK, Kristensen SR, Bak S, Atar D, Høilund-Carlsen PF, Mickley H (2006)
Frequency and significance of troponin T elevation in acute ischemic stroke
Am J Cardiol, 99 (1), 108-12
DOI 10.1016/j.amjcard.2006.07.071, PubMed 17196472

Jonsson G, Abdelnoor M, Landaas S, Muller C, Kjeldsen SE, Os I, Westheim A (2006)
N-terminal pro-B-type natriuretic peptide in risk stratification after acute myocardial infarction in patients on long-term beta-adrenergic receptor blocker therapy
Cardiology, 106 (2), 102-8
DOI 10.1159/000092743, PubMed 16636540

Julius S, Weber MA, Kjeldsen SE, McInnes GT, Zanchetti A, Brunner HR, Laragh J, Schork MA, Hua TA, Amerena J, Balazovjech I, Cassel G, Herczeg B, Koylan N, Magometschnigg D, Majahalme S, Martinez F, Oigman W, Seabra Gomes R, Zhu JR (2006)
The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy
Hypertension, 48 (3), 385-91
DOI 10.1161/01.HYP.0000236119.96301.f2, PubMed 16864741

Kastl SP, Speidl WS, Kaun C, Rega G, Assadian A, Weiss TW, Valent P, Hagmueller GW, Maurer G, Huber K, Wojta J (2006)
The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via NF-kappaB activation
J Thromb Haemost, 4 (8), 1790-7
DOI 10.1111/j.1538-7836.2006.02046.x, PubMed 16879222

Katz T, Alkalay D, Rath E, Atar D, Sukenik S (2006)
Bilateral simultaneous rupture of the quadriceps tendon in an adult amateur tennis player
J Clin Rheumatol, 12 (1), 32-3
DOI 10.1097/01.rhu.0000200421.43348.05, PubMed 16484878

Kjeldsen SE, Strand A, Julius S, Okin PM (2006)
Mechanism of angiotensin II type 1 receptor blocker action in the regression of left ventricular hypertrophy
J Clin Hypertens (Greenwich), 8 (7), 487-92
DOI 10.1111/j.1524-6175.2006.05366.x, PubMed 16849902

Kragelund C, Grønning B, Omland T, Køber L, Strande S, Steffensen R, Hildebrandt P (2006)
Is N-terminal pro B-type natriuretic peptide (NT-proBNP) a useful screening test for angiographic findings in patients with stable coronary disease?
Am Heart J, 151 (3), 712.e1-712.e7
DOI 10.1016/j.ahj.2005.12.009, PubMed 16504637

Kragelund C, Gustafsson I, Omland T, Grønning B, Køber L, Faber J, Strande S, Steffensen R, Hildebrandt P (2006)
Prognostic value of NH2-terminal pro B-type natriuretic peptide in patients with diabetes and stable coronary heart disease
Diabetes Care, 29 (6), 1411-3
DOI 10.2337/dc06-0227, PubMed 16732036

Larsen KO, Sjaastad I, Svindland A, Krobert KA, Skjønsberg OH, Christensen G (2006)
Alveolar hypoxia induces left ventricular diastolic dysfunction and reduces phosphorylation of phospholamban in mice
Am J Physiol Heart Circ Physiol, 291 (2), H507-16
DOI 10.1152/ajpheart.00862.2005, PubMed 16582020

Larstorp AC, Lund Søraas C, Tønnessen T, Müller C, Kjeldsen SE, Mangschau A (2006)
Scintigraphic demonstration of myocardial perfusion and ischaemia associated with coronary artery bypass grafting
Scand Cardiovasc J, 40 (6), 354-62
DOI 10.1080/14017430601004063, PubMed 17118826

Louch WE, Mørk HK, Sexton J, Strømme TA, Laake P, Sjaastad I, Sejersted OM (2006)
T-tubule disorganization and reduced synchrony of Ca2+ release in murine cardiomyocytes following myocardial infarction
J Physiol, 574 (Pt 2), 519-33
DOI 10.1113/jphysiol.2006.107227, PubMed 16709642

Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Grøgaard HK, Bjørnerheim R, Brekke M, Müller C, Hopp E, Ragnarsson A, Brinchmann JE, Forfang K (2006)
Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction
N Engl J Med, 355 (12), 1199-209
DOI 10.1056/NEJMoa055706, PubMed 16990383

Madsen LH, Christensen G, Lund T, Serebruany VL, Granger CB, Hoen I, Grieg Z, Alexander JH, Jaffe AS, Van Eyk JE, Atar D (2006)
Time course of degradation of cardiac troponin I in patients with acute ST-elevation myocardial infarction: the ASSENT-2 troponin substudy
Circ Res, 99 (10), 1141-7
DOI 10.1161/01.RES.0000249531.23654.e1, PubMed 17038641

Maggioni AP, Darne B, Atar D, Abadie E, Pitt B, Zannad F, 5th Cardiovascular Clinical Trialists Workshop (2006)
FDA and CPMP rulings on subgroup analyses
Cardiology, 107 (2), 97-102
DOI 10.1159/000094508, PubMed 16847375

Malinin A, Pokov A, Spergling M, Defranco A, Schwartz K, Schwartz D, Mahmud E, Atar D, Serebruany V (2006)
Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study
Thromb Res, 119 (3), 277-84
DOI 10.1016/j.thromres.2006.01.019, PubMed 16563469

Mistry NB, Westheim AS, Kjeldsen SE (2006)
The angiotensin receptor antagonist valsartan: a review of the literature with a focus on clinical trials
Expert Opin Pharmacother, 7 (5), 575-81
DOI 10.1517/14656566.7.5.575, PubMed 16553573

Mistry NB, Westheim AS, Kjeldsen SE (2006)
Treatment of hypertension in patients with congestive cardiac failure
Heart Fail Monit, 5 (2), 38-43
PubMed 16816875

Neverdal NO, Knudsen CW, Husebye T, Vengen OA, Pepper J, Lie M, Tønnessen T (2006)
The effect of aortic valve replacement on plasma B-type natriuretic peptide in patients with severe aortic stenosis--one year follow-up
Eur J Heart Fail, 8 (3), 257-62
DOI 10.1016/j.ejheart.2005.08.004, PubMed 16466963

Nilsson pM, Cifkova R, Kjeldsen SE (2006)
Treatment of Hypertension in patients with type-2 diabetes mellitus
Blood Press, 15 (1), 62-3
DOI 10.1080/080370505100088999, PubMed 16566081

Nylaende M, Abdelnoor M, Stranden E, Morken B, Sandbaek G, Risum Ø, Jørgensen JJ, Lindahl AK, Arnesen H, Seljeflot I, Kroese AJ (2006)
The Oslo balloon angioplasty versus conservative treatment study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication
Eur J Vasc Endovasc Surg, 33 (1), 3-12
DOI 10.1016/j.ejvs.2006.08.007, PubMed 17055756

Nylaende M, Kroese A, Stranden E, Morken B, Sandbaek G, Lindahl AK, Arnesen H, Seljeflot I (2006)
Prothrombotic activity is associated with the anatomical as well as the functional severity of peripheral arterial occlusive disease
Thromb Haemost, 95 (4), 702-7
DOI 10.1160/TH06-01-0007, PubMed 16601842

Nylaende M, Kroese A, Stranden E, Morken B, Sandbaek G, Lindahl AK, Arnesen H, Seljeflot I (2006)
Markers of vascular inflammation are associated with the extent of atherosclerosis assessed as angiographic score and treadmill walking distances in patients with peripheral arterial occlusive disease
Vasc Med, 11 (1), 21-8
DOI 10.1191/1358863x06vm662oa, PubMed 16669409

O'Donnell MJ, Berge E, Sandset PM (2006)
Are there patients with acute ischemic stroke and atrial fibrillation that benefit from low molecular weight heparin?
Stroke, 37 (2), 452-5
DOI 10.1161/01.STR.0000198887.81948.74, PubMed 16410483

Okin PM, Devereux RB, Gerdts E, Snapinn SM, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Lindholm LH, Dahlöf B, LIFE Study Investigators (2006)
Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study
Circulation, 113 (12), 1588-96
DOI 10.1161/CIRCULATIONAHA.105.574822, PubMed 16534012

Okin PM, Wachtell K, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Julius S, Lindholm LH, Nieminen MS, Edelman JM, Hille DA, Dahlöf B (2006)
Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension
JAMA, 296 (10), 1242-8
DOI 10.1001/jama.296.10.1242, PubMed 16968848

Olsen MH, Wachtell K, Dahlöf B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Lyle PA, Nieminen MS (2006)
The effect of losartan compared with atenolol on the incidence of revascularization in patients with hypertension and electrocardiographic left ventricular hypertrophy. The LIFE study
J Hum Hypertens, 20 (6), 460-4
DOI 10.1038/sj.jhh.1002013, PubMed 16572193

Olsen MH, Wachtell K, Ibsen H, Lindholm LH, Dahlöf B, Devereux RB, Kjeldsen SE, Oikarinen L, Okin PM, LIFE Study Investigators (2006)
Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study
J Hypertens, 24 (4), 775-81
DOI 10.1097/01.hjh.0000217862.50735.dc, PubMed 16531808

Olsen MH, Wachtell K, Nielsen OW, Hall C, Wergeland R, Ibsen H, Kjeldsen SE, Devereux RB, Dahlöf B, Hildebrandt PR (2006)
N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy
J Hypertens, 24 (8), 1531-9
DOI 10.1097/01.hjh.0000239288.10013.04, PubMed 16877955

Os I, Gudmundsdottir H, Kjeldsen SE, Oparil S (2006)
Treatment of isolated systolic hypertension in diabetes mellitus type 2
Diabetes Obes Metab, 8 (4), 381-7
DOI 10.1111/j.1463-1326.2005.00523.x, PubMed 16776744

Palatini P, Benetos A, Grassi G, Julius S, Kjeldsen SE, Mancia G, Narkiewicz K, Parati G, Pessina AC, Ruilope LM, Zanchetti A, European Society of Hypertension (2006)
Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting
J Hypertens, 24 (4), 603-10
DOI 10.1097/01.hjh.0000217838.49842.1e, PubMed 16531784

Polinski JM, Patrick A, Truppo C, Breiner L, Chen YT, Egan C, Jan S, Patel M, Weiss TW, Solomon DH (2006)
Interactive voice response telephone calls to enhance bone mineral density testing
Am J Manag Care, 12 (6), 321-5
PubMed 16756451

Schumacher A, Peersen K, Sommervoll L, Seljeflot I, Arnesen H, Otterstad JE (2006)
Physical performance is associated with markers of vascular inflammation in patients with coronary heart disease
Eur J Cardiovasc Prev Rehabil, 13 (3), 356-62
DOI 10.1097/01.hjr.0000188244.54287.96, PubMed 16926664

Serebruany V, Malinin A, Pokov A, Arora U, Atar D, Angiolillo D (2006)
Effects of escalating doses of tirofiban on platelet aggregation and major receptor expression in diabetic patients: hitting the TARGET in the TENACITY trial?
Thromb Res, 119 (2), 175-81
DOI 10.1016/j.thromres.2006.02.004, PubMed 16546241

Sever P, Dahlöf B, Poulter N, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen S, Kristinsson A, McInnes G, Mehlsen J, Nieminem M, O'Brien E, Ostergren J, ASCOT Steering Committee Members (2006)
Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial
Eur Heart J, 27 (24), 2982-8
DOI 10.1093/eurheartj/ehl403, PubMed 17145722

Solheim S, Pettersen AA, Arnesen H, Seljeflot I (2006)
No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease
Thromb Haemost, 96 (5), 660-4
DOI 10.1160/TH06-06-0337, PubMed 17080224

Solomon DH, Polinski JM, Truppo C, Egan C, Jan S, Patel M, Weiss TW, Chen YT, Brookhart MA (2006)
Access to bone mineral density testing in patients at risk for osteoporosis
Osteoporos Int, 17 (12), 1749-54
DOI 10.1007/s00198-006-0180-4, PubMed 16855862

Strand AH, Gudmundsdottir H, Os I, Smith G, Westheim AS, Bjørnerheim R, Kjeldsen SE (2006)
Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years
J Hypertens, 24 (5), 905-13
DOI 10.1097/01.hjh.0000222761.07477.7b, PubMed 16612253

Swift F, Strømme TA, Amundsen B, Sejersted OM, Sjaastad I (2006)
Slow diffusion of K+ in the T tubules of rat cardiomyocytes
J Appl Physiol (1985), 101 (4), 1170-6
DOI 10.1152/japplphysiol.00297.2006, PubMed 16763106

Søyseth V, Brekke PH, Smith P, Omland T (2006)
Statin use is associated with reduced mortality in COPD
Eur Respir J, 29 (2), 279-83
DOI 10.1183/09031936.00106406, PubMed 17050558

Tonstad S, Andrew Johnston J (2006)
Cardiovascular risks associated with smoking: a review for clinicians
Eur J Cardiovasc Prev Rehabil, 13 (4), 507-14
DOI 10.1097/01.hjr.0000214609.06738.62, PubMed 16874138

Trøseid M, Hjerkinn EM, Seljeflot I, Klemsdal TO, Bergengen L, Breivik L, Arnesen H (2006)
Comparison of biochemical, functional and structural aspects of arterial wall properties in elderly men
Scand J Clin Lab Invest, 66 (2), 137-45
DOI 10.1080/00365510500474462, PubMed 16537247

Tveit A, Grundvold I, Olufsen M, Seljeflot I, Abdelnoor M, Arnesen H, Smith P (2006)
Candesartan in the prevention of relapsing atrial fibrillation
Int J Cardiol, 120 (1), 85-91
DOI 10.1016/j.ijcard.2006.08.086, PubMed 17113170

Ueland T, Espevik T, Kjekshus J, Gullestad L, Omland T, Squire IB, Frøland SS, Mollnes TE, Dickstein K, Aukrust P (2006)
Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction
J Card Fail, 12 (8), 659-63
DOI 10.1016/j.cardfail.2006.07.002, PubMed 17045187

Yndestad A, Vinge LE, Bjørnerheim R, Ueland T, Wang JE, Frøland SS, Attramadal H, Aukrust P, Oie E (2006)
Thalidomide attenuates the development of fibrosis during post-infarction myocardial remodelling in rats
Eur J Heart Fail, 8 (8), 790-6
DOI 10.1016/j.ejheart.2006.02.007, PubMed 16549389

Zanchetti A, Julius S, Kjeldsen S, McInnes GT, Hua T, Weber M, Laragh JH, Plat F, Battegay E, Calvo-Vargas C, Cieśliński A, Degaute JP, Holwerda NJ, Kobalava J, Pedersen OL, Rudyatmoko FP, Siamopoulos KC, Störset O (2006)
Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial
J Hypertens, 24 (11), 2163-8
DOI 10.1097/01.hjh.0000249692.96488.46, PubMed 17053536

Aas AM, Seljeflot I, Torjesen PA, Diep LM, Thorsby PM, Birkeland KI (2006)
Blood glucose lowering by means of lifestyle intervention has different effects on adipokines as compared with insulin treatment in subjects with type 2 diabetes
Diabetologia, 49 (5), 872-80
DOI 10.1007/s00125-006-0205-8, PubMed 16555056